Pharmaceuticals

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts By Service (Bio-analysis & DMPK Studies, Toxicology, and Other Services); End User (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies), and Geography

  • THE3276294
  • 139 Pages
  • September 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
The global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018. The pre-clinical CROs market is estimated to grow with a CAGR of 8.1% from 2019-2027.

The market is driven by factors such as, increasing R&D expenditures and higher cost of drug development process in developed countries. However, dearth of skilled professionals may limit the growth of the market to a certain extent.

Increasing R&D expenditures made by the companies has been driving the growth of the pre-clinical CROs market. Research & development (R&D) is a significant and essential part of a company’s business. Pharmaceutical and biotech companies majorly focus on research and development (R&D) to come up with new molecules for various therapeutic applications with the most significant medical and commercial potential. The companies invest majorly on the R&Ds intending to deliver high quality and innovative products to the market. R&D investments made by biopharmaceutical companies has increased over the years. As per a report published by Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies has increased from US$49.6 billion in 2012 to US$ 58.8 billion in 2015. R&D not only leads to huge investment but also leads to the involvement of several years. The process from early detection or design to development to regulatory approval can take more than 10 to 15 years. Throughout the development phase of a drug substance, various testing services are required to check the quality and efficacy of the product. Hence, the pharmaceutical and biotech companies prefer to outsource the services to the contract research organizations (CROs) to save the cost and time, which is expected to drive the growth of the market.

Global pre-clinical CROs were segmented by service and end user. Based on the service segment, the market is categorized as, bio-analysis & DMPK studies, toxicology, and other services. On the basis of end user, the market is classified as, biopharmaceutical companies, government & academic institutes, and medical device companies.

Some of the major primary and secondary sources included in the report include, World Health Organization, Association of Clinical Research Organization, European Federation of Pharmaceutical Industries and Associations, European CRO Federation, and Pharmaceutical Research and Manufacturers of America, among others.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Pre-Clinical CROs Market – By Service

1.3.2 Global Pre-Clinical CROs Market – By End User

1.3.3 Global Pre-Clinical CROs Market – By Geography

2. Global Pre-Clinical CROs Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Pre-Clinical CROs Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East & Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Expert Opinions

5. Global Pre-Clinical CROs Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing R&D Expenditures

5.1.2 Higher Cost of Drug Development Process in Developed Countries

5.2 Key Market Restraint

5.2.1 Dearth of Skilled Professionals

5.3 Key Market Opportunities

5.3.1 Rising Biosimilars and Biologics Market

5.4 Future Trends

5.4.1 Increasing Number of Clinical Trials

5.5 Impact Analysis

6. Pre-Clinical CROs Market – Global Analysis

6.1 Global Pre-Clinical CROs Market Revenue Forecasts And Analysis

6.2 Global Pre-Clinical CROs Market, By Geography - Forecasts And Analysis

6.3 Performance of Key Players

7. Global Pre-Clinical CROs Market Analysis– by Service

7.1 Overview

7.2 Global Pre-Clinical CROs Market, By Service 2018 & 2027 (%)

7.3 Bio-Analysis and DMPK Studies Market

7.3.1 Overview

7.3.2 Global Bio-Analysis and DMPK Studies Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3 Toxicology Market

7.3.3.1 Overview

7.3.3.2 Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4 Other Services Market

7.3.4.1 Overview

7.3.4.2 Global Other Services Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Pre-Clinical CROs Market Analysis – by End User

8.1 Overview

8.2 Global Pre-Clinical CROs Market, By End User 2018 & 2027 (%)

8.3 Biopharmaceutical Companies Market

8.3.1 Overview

8.3.2 Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Government & Academic Institutes Market

8.4.1 Overview

8.4.2 Global Government & Academic Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Medical Device Companies Market

8.5.1 Overview

8.5.2 Global Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9. Pre-Clinical CROs Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1 North America Pre-Clinical CROs Market

9.1.1 Overview

9.1.2 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.4 North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.5 North America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.1.6 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1 US Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.6.3 US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1 Canada Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.7.3 Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.8 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1 Mexico Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.1.8.3 Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2 Europe Pre-Clinical CROs Market

9.2.1 Overview

9.2.2 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.3 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.4 Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.5 Europe Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.2.6 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1 UK Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.6.3 UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.7 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1 Germany Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.7.3 Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.8 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1 France Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.8.3 France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.9 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1 Italy Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.2 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.9.3 Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.10 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.1 Spain Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.2 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.2.10.3 Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3 Asia Pacific Pre-Clinical CROs Market

9.3.1 Overview

9.3.2 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.4 Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.5 Asia Pacific Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.3.6 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1 China Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.2 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.6.3 China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.7 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1 India Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.2 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.7.3 India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.8 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.1 Japan Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.2 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.8.3 Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.9 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1 Australia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.2 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.9.3 Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.10 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.1 South Korea Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.2 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.3.10.3 South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4 Middle East & Africa Pre-Clinical CROs Market

9.4.1 Overview

9.4.2 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.3 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.4 Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.5 Middle East & Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.4.6 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1 South Africa Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.2 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.6.3 South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.7 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.1 Saudi Arabia Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.2 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.7.3 Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4.8 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1 UAE Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.2 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.4.8.3 UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5 South And Central America Pre-Clinical CROs Market

9.5.1 Overview

9.5.2 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.4 South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.5 South and Central America Pre-Clinical CROs Market Revenue and Forecasts to 2027, By Country (%)

9.5.6 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.1 Argentina Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.2 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.6.3 Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.7 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1 Brazil Pre-Clinical CROs Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.2 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

9.5.7.3 Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. Pre-Clinical CROs Market – Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Pre-Clinical CROs Market, 2016-2019

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)

10.4.1 Expansion & Other Activities

10.4.1.1 Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market

10.4.2 Product Launches

10.4.2.1 Recent Product Launches By Players In The Pre-Clinical CROs Market

10.5 Inorganic Growth Strategies

10.5.1 Overview

10.6 Inorganic Growth Strategies in the Pre-Clinical CROs Market, 2016-2019 (%)

10.6.1 Acquisitions

10.6.1.1 Recent Acquisitions By Players In The Pre-Clinical CROs Market

10.6.2 Agreements & Collaborations

10.6.2.1 Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market

10.6.3 Partnerships

10.6.3.1 Recent Partnerships By Players In The Pre-clinical CROs Market

11. Pre-Clinical CROs Market–Key Company Profiles

11.1 MD Biosciences, Inc.

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Services Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 WuXi AppTec

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Overview

11.2.4 Service Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Pharmaceutical Product Development, LLC.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Overview

11.3.4 Service Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Covance Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Information

11.4.4 Service Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Charles River

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Services Portfolio

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 PRA Health Sciences, Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Overview

11.6.4 Service Portfolio

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medpace

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Service Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Parexel International Corporation

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Information

11.8.4 Service Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 ICON Plc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Service Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Eurofins Scientific

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. R&D Investments by Major Pharmaceutical Companies

Table 2. R&D Investments by PhRMA Member Companies,2016

Table 3. Number of Studies Registered for Clinical Trials

Table 4. North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 5. North America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 6. US: R&D Investments by Pharmaceutical Companies, (2015-2016)

Table 7. US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 8. US Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 9. Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 10. Canada Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 11. Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 12. Mexico Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 13. Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 14. Europe Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 15. UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 16. UK Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 17. Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 18. Germany Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 19. France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 20. France Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 21. Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 22. Italy Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 23. Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 24. Spain Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 25. Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 26. Asia Pacific Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 27. China: Major global pharmaceutical companies by R&D investments, 2013

Table 28. China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 29. China Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 30. India: R&D spending of Pharmaceutical companies (2010 & 2017)

Table 31. India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 32. India Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 33. Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 34. Japan Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 35. Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 36. Australia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 37. South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 38. South Korea Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 39. Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 40. Middle East & Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 41. South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 42. South Africa Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 43. Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 44. Saudi Arabia Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 45. UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 46. UAE Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 47. South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 48. South and Central America Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 49. Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 50. Argentina Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 51. Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By Service (US$ Mn)

Table 52. Brazil Pre-Clinical CROs Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 53. Recent Expansion & Other Activities By Players In The Pre-Clinical CROs Market

Table 54. Recent Product Launches in the Pre-Clinical CROs Market

Table 55. Recent Acquisitions By Players In The Pre-Clinical CROs Market

Table 56. Recent Agreements & Collaborations By Players In The Pre-Clinical CROs Market

Table 57. Recent Partnerships By Players In The Pre-clinical CROs Market

Table 58. Glossary of Terms, Pre-Clinical CROs Market

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370